Guangzhou Wondfo Biotech Co., Ltd signed the share transfer agreement with Chen Quangen to acquire 51% stake in Nanning Quanmaijie Medical Equipment Co., Ltd. for CNY 3.8 million.
January 19, 2017
Share
Guangzhou Wondfo Biotech Co., Ltd (SZSE:300482) signed the share transfer agreement with Chen Quangen to acquire 51% stake in Nanning Quanmaijie Medical Equipment Co., Ltd. for CNY 3.8 million on January 18, 2017. The transaction is subject to approval of Board of Guangzhou Wondfo Biotech Co., Ltd and not subject to approval by shareholders of Guangzhou Wondfo Biotech Co., Ltd.
Guangzhou Wondfo Biotech Co Ltd is a China-based company principally engaged in research, manufacture and sales of point-of-care testing (POCT) reagents, POCT instrument and related products. According to the testing result, the Company' products can be divided into qualitative testing products and quantitative testing products. According to the usage, the Company' products include pregnancy testing series, infectious diseases testing series, drugs (drug abuse) testing series and chronic disease testing series. The Company's products are used in POCT, clinical test, field test and personal health management, and other fields.
Guangzhou Wondfo Biotech Co., Ltd signed the share transfer agreement with Chen Quangen to acquire 51% stake in Nanning Quanmaijie Medical Equipment Co., Ltd. for CNY 3.8 million.
GUANGZHOU WONDFO BIOTECH CO.,LTD 
